Please login to the form below

Not currently logged in

Business as usual

MHRA explains that its emphasis will remain firmly on vetting when it comes to pharma advertising

Managing real world data governance

An aspirational framework to make the most of data and its role in improving patient care

Does safety sell medicines?

Is pharmacovigilance unnecessary policing or a strategic asset for pharma companies?

A new route to market

Despite regulation becoming more harmonised, SME expansion still presents complex access challenges

Should we be concerned about medical progress?

Medical progress, health expenditure, ageing populations and the future of our healthcare systems


Customer engagement design in pharma

In recent years pharma has slowly been realising the importance of customer experience and the fact that the commercial model that served it so well for the past 30 years

Rare diseases: Regulatory and reimbursement submissions, the challenges

Companies developing rare disease treatments face several unique challenges when it comes to regulatory and reimbursement submissions.

Meaningful digital initiatives need face time

Doctors are increasingly using social media and other online channels to search for and share information, but face-to-face interactions still carry more trust and are more likely to influence prescribing.

Authentic Engagement in Healthcare

Authentic Engagement in Healthcare thumbWhat does ‘authenticity’ mean to the healthcare sector and how can companies best build authentic relationships with their stakeholders?

Country reports

The death of the cancer drugs fund?

UK flagNHS England's siloed budget and its uncertain future

Is obesity really a problem in Brazil?

Obesity is on the rise in low- and middle-income countries, particularly in urban settings

Turkey: A growing pharma market with huge potential

The Turkish biopharma market offers many opportunities - if it can overcome its sustainability challenge


The challenge of antimicrobial resistance

Cubist Patrick-Vink Cubist's Patrick Vink on the company's ambitions in anti-infectives

Switching to a virtual healthcare system

babylon virtual health service Ali Parsa, CEO and founder of babylon, discusses the benefits of conducting healthcare consultations via a smartphone

The role of artificial intelligence in healthcare

Watson on jeopardy IBM's Amer Fasihi on the rise of Watson

White papers

Junior Doctor contracts – PR winners and losers

GCI Health's Caroline Howley on who's winning the PR battle around the junior doctors' strike.

How to get faster results with digital communication

Everyone is under pressure to deliver results fast, so how can you speed up the positive effects of your e-detailing and multichannel communication? One proven answer is to get the

How to get management buy-in for content marketing

Pharma content marketing is still fairly new in the scheme of things for the pharma industry. In the conservative and traditional pharma industry that’s fraught with regulations, getting management buy-in

EY Life Sciences Sector Update

Asia-Pacific and Japan

Featured jobs

Subscribe to our email news alerts


Add my company
Serviceplan Health & Life

We are your creative global lead agency, your Pan-European hub and your worldwide network....